Metastatic Lung Lesions as a Preferred Resection Site for Immunotherapy With Tumor Infiltrating Lymphocytes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Metastatic Lung Lesions as a Preferred Resection Site for Immunotherapy With Tumor Infiltrating Lymphocytes

Published:2016-06 Issue:5 Volume:39 Page:218-222
ISSN:1524-9557
Container-title:Journal of Immunotherapy
language:en
Short-container-title:

Author:

Ben-Avi Ronny,Itzhaki Orit,Simansky David,Zippel Dov,Markel Gal,Ben Nun Alon,Schachter Jacob,Besser Michal J.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology,Immunology,Immunology and Allergy

Reference31 articles.

1. Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data;Lancet,2010

2. Clinical responses in a phase II study using adoptive transfer of short-term cultured tumor infiltration lymphocytes in metastatic melanoma patients;Besser;Clin Cancer Res,2010

3. Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens;Dudley;J Clin Oncol,2008

4. Adoptive immunotherapy of advanced melanoma;Shapira-Frommer;Curr Treat Options Oncol,2012

5. Advances in the treatment of metastatic melanoma: adoptive T-cell therapy;Bernatchez;Semin Oncol,2012

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumour-infiltrating lymphocyte therapy for patients with advanced-stage melanoma;Nature Reviews Clinical Oncology;2024-01-08

2. Application of adoptive cell therapy in hepatocellular carcinoma;Immunology;2023-07-12

3. Adoptive Cellular Therapy for Metastatic Melanoma: The Road to Commercialization and Treatment Guidelines for Clinicians;Annals of Surgical Oncology;2022-09-16

4. Prognostic and therapeutic TILs of cervical cancer—Current advances and future perspectives;Molecular Therapy - Oncolytics;2021-09

5. Tissue Harvesting for Adoptive Tumor Infiltrating Lymphocyte Therapy in Metastatic Melanoma;Anticancer Research;2019-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3